Pulmonary embolism associated with tranexamic acid in severe acquired haemophilia

European Journal of Haematology

Volumn 68, Issue 5, 2002, Pages 307-309

  Taparia, Minakshi ^a   Cordingley, Frank T ^a   Leahy, Michael F ^a  

^a FREMANTLE HOSPITAL   (Australia)

Author keywords

Factor VIII inhibitor; Thromboembolism; Tranexamic acid

Indexed keywords

BLOOD CLOTTING FACTOR 8 INHIBITOR; FIBRINOLYTIC AGENT; TRANEXAMIC ACID;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; DRUG HALF LIFE; GASTROINTESTINAL TOXICITY; HEMOPHILIA; HUMAN; LUNG EMBOLISM; MALE; PRIORITY JOURNAL; THROMBOEMBOLISM; VEIN THROMBOSIS;

ADULT; ANTIFIBRINOLYTIC AGENTS; AUTOANTIBODIES; FACTOR VIII; HEMOPHILIA A; HEMORRHAGE; HUMANS; MALE; PULMONARY EMBOLISM; TRANEXAMIC ACID;

EID: 0036342825     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0609.2002.01607.x     Document Type: Article

References (14)

1. Tranexamic acid. A review of its use in surgery and other indications
2. Epsilon-aminocaproic acid (E-ACA) as a therapeutic agent based on 5 years' clinical experience
3. Experimental and clinical studies on AMCA, the antifibrinolytically active isomer of p-aminomethyl cyclohexane carboxylic acid
4. Massive pulmonary thromboembolism after tranexamic acid antifibrinolytic therapy
5. Deep-vein thrombosis induced by tranexamic acid in idiopathic thrombocytopenic purpura
6. Tranexamic acid and intracranial thrombosis
7. Tranexamic acid and arterial thrombosis
8. Treatment with the fibrinolytic inhibitor tranexamic acid - Risk for thrombosis?
9. Clinical experiences with epsilon-aminocaproic acid (EACA) as an antifibrinolytic agent
10. Diskussion